CLINICAL_TRIALS
trial_result
· 2016-03-14
Clinical Trial Update: NeoVas Bioresorbable Coronary Scaffold First-in-Man Study [Phase 1]
Summary
Phase 1 first-in-man study of the NeoVas bioresorbable coronary scaffold by Lepu Medical; results are posted with the study status listed as UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lepu Medical Technology (Beijing) Co., Ltd. | Conditions: Coronary Artery Disease | Phase 1 | Status: UNKNOWN | Results posted: 2016-03-14